The Pathology AI Library

The library

ArteraAI Breast

Prognostic AI test using digital pathology images for breast cancer.

Cost
Paid
Your data
Not established
Licence
proprietary
Maturity
production
From
Artera, Inc.
Website

What it is

Prognostic algorithm applying the same digital-pathology approach as the company's prostate test to breast cancer.

Caveats

Clearance is specific to the indication for use stated in the FDA record and to the United States. It implies nothing about availability or approval elsewhere. Verify the current indication and your own jurisdiction's status before clinical use.

Related

arteraai-prostate

Catalogued 2026-08-02, last checked 2026-08-02. View the source record · Report an error